The rapid development of downstream in vitro diagnostic reagent industry feeds the transformation and upgrading of raw material industry. The development of in vitro diagnostic reagent raw material industry depends on the iteration of in vitro diagnostic reagent products and the expansion of market space. On the one hand, the innovation of in vitro diagnostic reagent application technology will introduce more new in vitro diagnostic reagent products to the market, which will not only replace the traditional product application in the terminal market, but also further force the transformation and upgrading of in vitro diagnostic reagent raw material suppliers. On the other hand, as disposable consumables for diagnostic applications, in vitro diagnostic reagents cannot be used for repeated consumption, which has a rigid market demand. The increasing market consumption of in vitro diagnostic reagents will drive the expansion of raw material market capacity.

A large amount of acidified sodium metasulfite or sodium bisulfite can be added to the waste liquid or splash of BRPG series in vitro diagnostic reagent bacteriostatic agents, these chemicals can easily neutralize the active components in BRPG series in vitro diagnostic reagent bacteriostatic agents deactivate it

1. This product is a new generation that does not contain CMIT (5-chloro-2-methyl-4-isothiazolin-3-one), AOX (adsorbable organic halides) and VOC (organic volatiles) synergistic enhancement. Effective fungicide

Nanchang Greenland International Expo Center.

BRPG series in vitro diagnostic reagent bacteriostatic agent is a high-efficiency, in vitro diagnostic reagent bacteriostatic agent specially used for in vitro diagnostic reagents, including flow in various reagents, quality controls, calibrators, buffers and chromatographic fluids Mutually.

The rapid development of the downstream in vitro diagnostic reagent industry has fed back the transformation and upgrading of the raw material industry.

At present, most companies have begun to attach importance to stability research content in the research and development process, but some companies still have many problems in the stability research materials submitted during the product registration process. like: